Atlas Trials

A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study

Clinical trial NCT01773070 · COMPLETED

Trial details

NCT number
NCT01773070
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C
Start date
2013-06-01
Primary completion
2016-10-01
Enrollment
478

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.